V2-receptor blockade enhances pressor response to vasopressin: Gender difference

Life Sciences

Volumn 59, Issue 8, 1996, Pages 695-703

  Wang, Yi Xin ^a   Crofton, Joan T ^a   Liu, Hanwu ^a   Sato, Kazutoshi ^a   Share, Leonard ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

antidiuresis; non peptide V2 antagonist; pressor response; sexual dimorphism; V2 vasodilator

Indexed keywords

MOZAVAPTAN; VASOPRESSIN; VASOPRESSIN ANTAGONIST; VASOPRESSIN V2 RECEPTOR; ARGIPRESSIN; BENZAZEPINE DERIVATIVE; VASOPRESSIN RECEPTOR;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DIURESIS; DOSE RESPONSE; ESTRUS CYCLE; FEMALE; GENDER; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; RAT; SEX DIFFERENCE; ANIMAL; BLOOD PRESSURE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; ESTRUS; HEART RATE; MALE; SEXUAL DEVELOPMENT; SPRAGUE DAWLEY RAT; TIME;

ANIMALIA;

ANIMALS; ARGININE VASOPRESSIN; BENZAZEPINES; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRUS; FEMALE; HEART RATE; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOPRESSIN; SEX CHARACTERISTICS; TIME FACTORS;

EID: 0030593322     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00351-7     Document Type: Article

References (42)

1. L. SHARE and J.T. CROFTON, Ann NY Acad Sci 689 438-454 (1993).
2. K. TOBA, J.T. CROFTON, M. INOUE, and L. SHARE, Am J Physiol 261 R1118-R1125(1991).
3. M.B. VALLOTTON, A.M. CAPPONI, E.I.M. JOHNSON , and U. LANG, Horm . Res. 24105-110(1990).
4. J.-F. LIARD, Circ. Res. 5J 631-640 (1986).
5. J.-F. LIARD, Clin.Sci.74 293-299(1988).
6. J.-F. LIARD, J. Cardiovasc. Pharmacol. 11:174-180 (1988).
7. J.-F. LIARD, Am. J. Physiol. 255 H1325-H1329 (1988).
8. J.-F. LIARD, Am. J. Physiol. 256 H1621-H1626 (1989).
9. J.-F. LIARD, Am. J. Physiol. 258 (Heart Circ Physiol 27) H482-H489 (1990).
10. J.-F. LIARD, Am. J. Physiol. 263 H1888-H1891 (1992).
11. J.-F. LIARD, Am. J. Physiol. 266 H99-H106 (1994).
12. D.G. BICHET, M. RAZI, M. LONEGRAN, M.F. ARTHUS, V. PAPUKNA, C. KORTAS, and J.N. BARJON, N. Engl. J. Med. 318 881-887 (1988).
13. D.G. BICHET, M. RAZI, M.F. ARTHUS, M. LONEGRAN, P. TITTLEY, R.K. SMILEY, G. ROCK, and D.J. HIRSCH, Kidney Int. 36 859-866 (1989).
14. F.H.M. DERKX, A.J. MAN INT VELD, R. JONES, J.L.REID, and M.A.D.H. SCHALEKAMP, J. Hypertens. 1(Suppl. 2) 58-61 (1983).
15. T.D.M. WILLIAMS,S.L. LIGHTMAN, and M.J. LEADBEATER, Clin. Endocrinol. 24 89-96 (1986).
16. B.R. WALKER, Am. J. Physiol. 251 (Heart Circ Physiol 20) H34-H39 ( 1986).
17. A.T. HIRSCH, V.J. DZAU, J.A. MAJZOUB, and M.A. CREAGER, J. Clin. Invest. 84 418-42 (1989).
18. J.T. CROFTON, L. SHARE, and D.P BROOKS, Am. J. Physiol. 255 R1041-R1048 (1988).
19. M. GELLAI and H. VALTIN , Kidney Int. 15 419-426 (1979).
20. M. GELLAI, J.H. SILVERSTEIN, J.-C. HWANG, F.T. LAROCHELLE JR, and H. VALTIN, Am. J. Physiol. 246 F819-F827 (1984).
21. Y.-X. WANG, R.M. EDWARDS, P. NAMBI, E.J. STACK, M. PULLEN, L. SHARE, J.T. CROFTON, and D.P. BROOKS, Am. J. Physiol. 265 R1284-R1290 (1993).
22. Y.-X. WANG, J.T. CROFTON , H-W LIU, D.P. BROOKS, and L. SHARE, Am. J. Physiol. 267 R536 - R 541 (1994).
23. Y.-X. WANG, J.T.CROFTON, H-W LIU, K. SATO, D.P BROOKS, and L. SHARE, Am. J. Physiol. 268 R951-R957 (1995).
24. Y. YAMAMURA, H. OGAWA, H. YAMASHITA, T. CHIHARA, H. MIYAMOTO, S. NAKAMURA, T. ONOGAWA, T. YAMASHITA, T. HOSOKAMA, M. MORI, M. TOMINAGA , and Y. YABUUCHI, Br. J. Pharmacol. 105 787-791 (1992).
25. J.H. ZAR , Englewood Cliffs, NJ: Prentice-Hall, Inc. (1989)
26. J. SCHWARTZ, J. -F. LIARD, and A.W. COWLEY, Am. J. Physiol. 249 H1001-H1008 (1985).
27. D.P. BROOKS, P.P. KOSTER, F.L. STASSEN, C.R. ALBRIGHTSON, W.F. HUFFMAN, M.A. WASSERMAN, and L.B. KINTER, Br. J. Pharmacol. 24 759-764 (1988).
28. J.T. CROFTON, D.L. RATLIFF, D.P. BROOKS, and L. SHARE, Endocrinol. 118 1777-1781 (1986).
29. F.H.M. DERKX, H.S. BRINK, P. MERKUS, J. SMITS, E.J.R. BROMMER, and M.A.D.H. SCHALEKAMP, J. Hypertens. 5.S107-S109 (1987).
30. K. HASUNUMA, K. YAMADE, Y. TAMURA, and S. YOSHIDA, Am. J. Physiol. 260 H1031-H1036(1991).
31. P.M. MANNUCCI, Annu. Rev. Med. 41 55-64 (1990).
32. K. YAMADA, M. NAKAYAMA, H. NAKANO, H. MIMURA, and S. YOSHIDA, Am. J. Physiol. 264 E203-E207 (1993).
33. J. N. STALLONE, Am. J. Physiol. 265 H2073-H2080 (1993).
34. A.W. COWLEY JR., E. MONOS, and A.C. GUYTON, Circ. Res. 14 505-514 (1974).
35. A.W. COWLEY JR., In: A.C. Guyton, J.E. HALL Ed. Cardiovascular Physiology IV. Baltimore:University Press, Vol. 26 pp. 189-242 (1982).
36. A.W.COWLEY and J.F. LIARD, Hypertension Dallas 11, (Suppl. I), I-25-I-32 (1988).
37. R.L. WEBB, J.W. OSBORN JR., and A.W. COWLEY JR, Am. J. Physiol. 251 (Heart Circ Physiol 20) H1244-H1251 (1986).
38. K. SHIMIZU, J. SCHWARTZ, and B.P. MCGRATH, Am. J. Physiol. 264 R345-R349 (1993).
39. Y. IMAI, P.L. NOLAN, and C.I. JOHNSTON, Circ. Res. 55 140-149 (1983).
40. B.L. BRIZZEE and B.R. WALKER, Am. J. Physiol. 258 R860-R868 (1990).
41. Y. AKI, T. TAMAKI, H. KIYOMOTO, H. HE, H. YOSHIDA, H. IWAO, and Y. ABE, J. Cardiovasc. Pharmacol. 23 (2) 331-336 (1994).
42. B.L. BRIZZEE, L. HARRISON-BERNARD, H.A. PRETUS, G.G. CLIFTON, and B.R. WALKER, Am. J. Phyiol. 255 R41-R46 (1988).